Citigroup Inc Ani Pharmaceuticals Inc Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 35,369 shares of ANIP stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,369
Previous 27,498
28.62%
Holding current value
$2.07 Million
Previous $1.64 Million
19.21%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ANIP
# of Institutions
211Shares Held
19.2MCall Options Held
3.4KPut Options Held
10.8K-
Black Rock Inc. New York, NY2.66MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$76.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$58.6 Million0.03% of portfolio
-
State Street Corp Boston, MA737KShares$43.1 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY700KShares$40.9 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.02B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...